Cheng Xiang

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0002-3435-0493

发表论文 72 篇 · 总被引 1640 次 · h-index 22

代表论文

Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways (2021 · Biochemical Pharmacology · 被引 83)
Pharmacological properties and therapeutic potential of berberine: a comprehensive review (2025 · Frontiers in Pharmacology · 被引 22)
Is transoral endoscopic thyroidectomy safe for total thyroidectomy compared to open thyroidectomy? A propensity‐score matched cohort study with papillary thyroid carcinoma (2023 · Journal of Surgical Oncology · 被引 13)
A Novel 5-HT1B Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease (2021 · Frontiers in Pharmacology · 被引 13)
Punicalin Attenuates Breast Cancer-Associated Osteolysis by Inhibiting the NF-κB Signaling Pathway of Osteoclasts (2021 · Frontiers in Pharmacology · 被引 11)
Procurement of medicines to treat cancer, 2015–2020, China (2022 · Bulletin of the World Health Organization · 被引 9)